Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Pyrvinium for Reversal of Precancerous Metaplasia and Dysplasia in the Stomach

NCT06782048 is registered in ClinicalTrials.gov with National University Hospital, Singapore as lead sponsor.

NCT NCT06782048
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT06782048 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Pyrvinium for Reversal of Precancerous Metaplasia and Dysplasia in the Stomach
Lead sponsor
National University Hospital, Singapore
Phase
Phase 2
Overall status
Not yet recruiting
Start date
November 30, 2026
Completion date
December 31, 2029
Enrollment
50 (estimated)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

stomach neoplasm